SCIENTIFIC BACKGROUND

CFTR

Category:

Scientific Background

Cystic fibrosis (CF) is one of the most common autosomal recessive inherited diseases in the Caucasian population (frequency 1:2500, frequency of carriers 1:25). Affected persons suffer from chronic pulmonary symptoms (frequent bronchopulmonary infections, persistent bronchiectasis) and gastrointestinal symptoms (pancreatic insufficiency, pancreatitis, meconium ileus (pre- or neonatal)), and male infertility is seen. It is caused by pathogenic changes in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which leads to the functional disruption of a chloride channel in the apical membrane of glandular epithelial cells and thus to a change in the salt content of sweat and other body secretions.

 

The most frequently detected pathogenic alteration of the CFTR gene in many populations is the variant p.Phe-508del (F508del). There are >2000 other pathogenic changes in the CFTR gene currently described that are significantly less frequent. The development of the disease depends on the type and severity of the CFTR variants. In addition to the classical, early manifesting and multisystemic cystic fibrosis, milder, monosymptomatic forms have also been described and are grouped under the so-called CFTR-RDs (related disorder). These include disseminated bronchiectasis, atypical chronic rhinosinusitis, chronic pancreatitis or CBAVD (congenital bilateral aplasia of the vas deferens).

 

Early diagnosis is of great importance with regard to optimal care of those affected. Molecular genetic diagnostics to confirm the suspected clinical diagnosis and determine the CFTR genotype can have a decisive influence on the later choice of therapy. CF diagnostics have also been part of newborn screening since 2016.

 

References

Goetz et Ren 2019, Pediatr Ann 48:e154 / Wiencek et Lo 2018, Clin Chem 64:898 / Sosnay et al. 2017, J Pediatr 181S:S52 / Farrell et al. 2017, J Pediatr 181S:S4 / Dequeker et al. 2009, Eur J Hum Genet 17:51 / Castellani et al. 2008, J Cyst Fibros 7:179 / Ogino et al. 2004 J Med Genet 41:e70 / Steiner et al. 2004, Hum Mutat 24:120 / Bobadilla et al. 2002, Hum Mutat 19:575 / Claustres et al. 2000, Hum Mutat 16:143

GENES

CFTR

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more